Invention Application
US20070213372A1 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
失效
取代的2,6-二氨基-3,5-二氰基-4-芳基吡啶及其作为腺苷受体选择配体的用途
- Patent Title: Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
- Patent Title (中): 取代的2,6-二氨基-3,5-二氰基-4-芳基吡啶及其作为腺苷受体选择配体的用途
-
Application No.: US11607262Application Date: 2006-12-01
-
Publication No.: US20070213372A1Publication Date: 2007-09-13
- Inventor: Ulrich Rosentreter , Thomas Kramer , Andrea Vaupel , Walter Hubsch , Nicole Diedrichs , Thomas Krahn , Klaus Dembowsky , Johannes-Peter Stasch
- Applicant: Ulrich Rosentreter , Thomas Kramer , Andrea Vaupel , Walter Hubsch , Nicole Diedrichs , Thomas Krahn , Klaus Dembowsky , Johannes-Peter Stasch
- Applicant Address: DE Leverkusen
- Assignee: Bayer Aktiengesellschaft
- Current Assignee: Bayer Aktiengesellschaft
- Current Assignee Address: DE Leverkusen
- Priority: DE10110747.1 20010307
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D213/02
Abstract:
The present invention relates to substituted 2,6-diamino-3,5-dicyano-4-arylpyridines of the formula (I) wherein the definitions of substituent groups R1-R7 are as provided in the specification and claims, to a pharmaceutical composition containing such a compound, to a process for preparation of such materials, and to their use as medicaments for the treatment of cardiovascular disorders and diabetes.
Public/Granted literature
- US08242281B2 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands Public/Granted day:2012-08-14
Information query
